268 related articles for article (PubMed ID: 9363909)
1. Heterogeneity in the polyclonal T cell response to birch pollen allergens.
Dormann D; Montermann E; Klimek L; Weber B; Ebner C; Valenta R; Kraft D; Reske-Kunz AB
Int Arch Allergy Immunol; 1997 Nov; 114(3):272-7. PubMed ID: 9363909
[TBL] [Abstract][Full Text] [Related]
2. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
[TBL] [Abstract][Full Text] [Related]
3. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.
Jahn-Schmid B; Siemann U; Zenker A; Bohle B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D; Ebner C
Int Immunol; 1997 Dec; 9(12):1867-74. PubMed ID: 9466314
[TBL] [Abstract][Full Text] [Related]
4. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
Mari A; Wallner M; Ferreira F
Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
[TBL] [Abstract][Full Text] [Related]
5. Detection of specific IgE antibodies in the sera of patients allergic to birch pollen using recombinant allergens Bet v 1, Bet v 2, Bet v 4: evaluation of different IgE reactivity profiles.
Rossi RE; Monasterolo G; Monasterolo S
Allergy; 2003 Sep; 58(9):929-32. PubMed ID: 12911423
[TBL] [Abstract][Full Text] [Related]
6. How far can we simplify in vitro diagnostics for Fagales tree pollen allergy? A study with three whole pollen extracts and purified natural and recombinant allergens.
Van Ree R; Van Leeuwen WA; Akkerdaas JH; Aalberse RC
Clin Exp Allergy; 1999 Jun; 29(6):848-55. PubMed ID: 10336603
[TBL] [Abstract][Full Text] [Related]
7. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
[TBL] [Abstract][Full Text] [Related]
8. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
[TBL] [Abstract][Full Text] [Related]
9. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the T cell response to the major hazelnut allergen, Cor a 1.04: evidence for a relevant T cell epitope not cross-reactive with homologous pollen allergens.
Bohle B; Radakovics A; Lüttkopf D; Jahn-Schmid B; Vieths S; Ebner C
Clin Exp Allergy; 2005 Oct; 35(10):1392-9. PubMed ID: 16238801
[TBL] [Abstract][Full Text] [Related]
11. Induction of IgE antibodies in mice and rhesus monkeys with recombinant birch pollen allergens: different allergenicity of Bet v 1 and Bet v 2.
Vrtala S; Mayer P; Ferreira F; Susani M; Sehon AH; Kraft D; Valenta R
J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):913-21. PubMed ID: 8939154
[TBL] [Abstract][Full Text] [Related]
12. Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin).
Ebner C; Hirschwehr R; Bauer L; Breiteneder H; Valenta R; Ebner H; Kraft D; Scheiner O
J Allergy Clin Immunol; 1995 May; 95(5 Pt 1):962-9. PubMed ID: 7751517
[TBL] [Abstract][Full Text] [Related]
13. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
[TBL] [Abstract][Full Text] [Related]
14. Reduced in vivo allergenicity of Bet v 1d isoform, a natural component of birch pollen.
Arquint O; Helbling A; Crameri R; Ferreira F; Breitenbach M; Pichler WJ
J Allergy Clin Immunol; 1999 Dec; 104(6):1239-43. PubMed ID: 10589007
[TBL] [Abstract][Full Text] [Related]
15. Allergens from birch pollen and pollen of the European chestnut share common epitopes.
Hirschwehr R; Jäger S; Horak F; Ferreira F; Valenta R; Ebner C; Kraft D; Scheiner O
Clin Exp Allergy; 1993 Sep; 23(9):755-61. PubMed ID: 10779306
[TBL] [Abstract][Full Text] [Related]
16. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
[TBL] [Abstract][Full Text] [Related]
17. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
18. Cross-reacting allergens in tree pollen and pollen-related food allergy: implications for diagnosis of specific IgE.
Scheiner O; Aberer W; Ebner C; Ferreira F; Hoffmann-Sommergruber K; Hsieh LS; Kraft D; Sowka S; Vanek-Krebitz M; Breiteneder H
Int Arch Allergy Immunol; 1997; 113(1-3):105-8. PubMed ID: 9130495
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.
Bauer L; Bohle B; Jahn-Schmid B; Wiedermann U; Daser A; Renz H; Kraft D; Ebner C
Clin Exp Immunol; 1997 Mar; 107(3):536-41. PubMed ID: 9067529
[TBL] [Abstract][Full Text] [Related]
20. Comparison of genetically engineered hypoallergenic rBet v 1 derivatives with rBet v 1 wild-type by skin prick and intradermal testing: results obtained in a French population.
Pauli G; Purohit A; Oster JP; De Blay F; Vrtala S; Niederberger V; Kraft D; Valenta R
Clin Exp Allergy; 2000 Aug; 30(8):1076-84. PubMed ID: 10931114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
